Rowan Street fund is up +20.1% (net of fees) year-to-date, capping off a remarkable three-year run. Read more here.

Glenmark Pharmaceuticals has announced that it received a warning letter from the U.S. Food and Drug Administration (FDA) for its manufacturing facility in Indore, Madhya Pradesh, India.

A report on Temasek’s latest investment performance may have left readers with the wrong impression that we are turning negative on the prospects for Europe and our investments in the region ( Report, ...

S&P 500 nears record high, completing stunning comeback from April sell-off. In analyzing the supply and demand of housing, ...

In an interview with ABC News, Kevin Hassett was also pressed about the president's decision to hit imports from Brazil with ...

In a rare bipartisan letter, Idaho state legislators celebrated the death of a federal proposal that would have allowed the ...

Troubled consumer credit provider Lipa Later has received offers of up to Sh3 billion from a Canadian company, a London-based ...

The disappearance of a 19-year-old Delhi University student, whose last known location was the Signature Bridge, has put the ...

The latest spat between the Trump administration and the Federal Reserve is sounding more like a home-improvement reality TV ...

German universities are facing the biggest austerity programme of the postwar era. State governments in Berlin and across the ...

JSW Paints plans to acquire Akzo Nobel India shares. They issued an offer to acquire up to 25.24% of the company's voting ...

Promoter group entities of VIP Industries have agreed to sell up to 58 per cent stake in the luggage company to a consortium of Multiples private equity for ₹3,200 crore, according to an exchange ...